OncoMAR

Brand IP Statement(s) re: (c), (TM), (SM)

This OncoMAR(TM) formula is a proprietary blend, delivering 5.5g (0.19 oz.) per 8-capsule packet of Avemar(R) Fermented Wheat Germ Extract, standardized to methoxy-substituted benzoquinones.

Precautions re: Allergies

Allergen Statement: This product contains wheat and yeast ingredients.

Formulation re: Does NOT Contain

DOES NOT CONTAIN: Corn protein, soy, animal or dairy products, artificial colors, artificial sweeteners, or preservatives.

Seals/Symbols

Convenient Easy To Swallow Vegetarian Capsule Formula!

Precautions re: All Other

• Pharmaceutical Grade • Professional Use Only

Precautions re: All Other

Consult with a healthcare professional for recommended usage levels for children, and for guidance on using more than 1 OncoMAR(TM) packet per day.

Precautions re: All Other

Do not consume OncoMAR(TM) if you have had an organ or tissue transplant, or if you are hypersensitive to wheat or yeast.

Precautions re: All Other

This product is not intended to be the sole source of nutrients in the diet.

FDA Statement of Identity

Dietary Supplement

Suggested/Recommended/Usage/Directions

Suggested Usage: As a dietary supplement for adults, take one 8-capsule packet of OncoMAR(TM) per day. Best absorbed on an empty stomach, 1 hour before or after food. Consume 2 hours before or after taking any drugs or other dietary supplements.

Precautions re: Children

CAUTIONS: Keep out of reach of children.

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Storage

STORAGE: Store in a cool dry place, 41-79(0)F (5-26(0)C).

General Statements: All Other Content

• Supports cell metabolic regulation*

General Statements: All Other Content

Patented

General Statements: All Other Content

This package is recyclable (recycle)

Precautions re: Pregnant or Nursing or Prescription Medications

Should not be taken during pregnancy or while nursing.

Brand IP Statement(s) re: (c), (TM), (SM)

XYMOGEN 2011

Brand IP Statement(s) re: (c), (TM), (SM)

All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.

Brand IP Statement(s) re: (c), (TM), (SM)

Avemar(R) Fermented Wheat Germ Freeze-Dried Extract Standardized to Methoxy-Substituted Benzoquinones

Brand IP Statement(s) re: (c), (TM), (SM)

OncoMAR(TM) is made under the supervision of the original inventor of Avemar(R), Mate Hidvegi, Ph. D. The development of Avemar(R) fermented wheat germ extract has become the life’s work of Dr. Hidvegi. He was inspired to build upon the theories and experiments of Hungarian Nobel Prize winner, Dr. Albert Szent-Gyorgyi. Dr. Hidvegi’s patented processes yield a consistency effective standardized extract that has been extensively researched. Avemar(R) has been the subject of over 100 studies in cell lines, with animals and clinical trials, reported in more than 30 articles in medical peer-reviewed journals. Improving on his original patented, fermented wheat germ-processing method, he has now created OncoMAR(TM) in vegetarian capsule form – so this unique dietary supplement is easier than ever to take on a daily basis. Improvements include utilizing low temperature freeze-drying, which eliminates the need to use maltodextrin as a stabilizer, and removing the sweetener and flavoring. As a result, OncoMAR(TM) contains 99% less stabilizing and flavoring additives, while maintaining the same quality of Avemar(R) fermented wheat germ actives as used in clinical trials.** **Subjects in clinical trials consumed 8.5g per day of Avemar(R) pulvis, consisting of 5.5g Avemar(R) fermented wheat germ actives with 3g maltodextrin, a non-active stabilizer. Each packet of 8 OncoMAR(TM) Capsules contains 5.5g Avemar(R) fermented wheat germ actives, without maltodextrin.

General Statements: All Other Content

Exclusive Professional Formulas

General: Product/Version Code

REV. 102111